69f73cc3_anderbilt_Ingram_Cancer_Center__Trial_Type
[Protocol No. & Open Date] VICCURO1450 08/13/2014 [Summary] PROSPER: A Multinational, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Enzalutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer [Trial Type] 
Treatment Prostate
Urologic / Genitourinary Cancers - Vanderbilt-Ingram Cancer Center
Trial Type